ConductScience.org, home

Paper2832604

Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.

Portoghese PS and 4 others. J Med Chem, 1988. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. Papers, record 2832604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2832604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
PubMed
Journal
J Med Chem
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
5.45
iCite
Revised in PubMed
2019-07-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Portoghese PSP S
2Nagase HH
3Lipkowski AWA W
4Larson DLD L
5Takemori AEA E

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NaltrexoneMajor topic
Receptors, OpioidMajor topic
Animals
Chemical Phenomena
Chemistry
Cyclazocine
Enkephalin, Leucine
Enkephalin, Leucine-2-Alanine
Ethylketocyclazocine
Guinea Pigs
Male
Mice
Models, Molecular
Morphine
Muscle, Smooth
Receptors, Opioid, kappa
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
41083597Kappa opioid receptor control of motivated behavior revisited.Neuropsychopharmacology2026https://conductscience.org/library/papers/41083597PubMed
33489124Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease.Clin Transl Immunology2021https://conductscience.org/library/papers/33489124PubMed
33174064Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.Handb Exp Pharmacol2022https://conductscience.org/library/papers/33174064PubMed
32792571Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia.Sci Rep2020https://conductscience.org/library/papers/32792571PubMed
32714584Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?Neuronal Signal2018https://conductscience.org/library/papers/32714584PubMed
314990012016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.J Med Chem2020https://conductscience.org/library/papers/31499001PubMed
31162938Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.FASEB J2019https://conductscience.org/library/papers/31162938PubMed
29492614The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats.Psychopharmacology (Berl)2018https://conductscience.org/library/papers/29492614PubMed
29038479Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships.Sci Rep2017https://conductscience.org/library/papers/29038479PubMed
28128928A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.ACS Chem Neurosci2017https://conductscience.org/library/papers/28128928PubMed
27213169Major Depressive Disorder and Kappa Opioid Receptor Antagonists.Transl Perioper Pain Med2016https://conductscience.org/library/papers/27213169PubMed
26959173An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.J Med Chem2016https://conductscience.org/library/papers/26959173PubMed
26005355Nalfurafine hydrochloride to treat pruritus: a review.Clin Cosmet Investig Dermatol2015https://conductscience.org/library/papers/26005355PubMed
24973818Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists.Bioorg Med Chem2014https://conductscience.org/library/papers/24973818PubMed
22642416Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.BMC Pharmacol2012https://conductscience.org/library/papers/22642416PubMed
22538196Receptor-targeting mechanisms of pain-causing toxins: How ow?Toxicon2012https://conductscience.org/library/papers/22538196PubMed
22354464Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Org Biomol Chem2012https://conductscience.org/library/papers/22354464PubMed
20137938Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.Bioorg Med Chem Lett2010https://conductscience.org/library/papers/20137938PubMed
19954245
Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
J Med Chem2009https://conductscience.org/library/papers/19954245PubMed
19099466Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse.J Nat Prod2009https://conductscience.org/library/papers/19099466PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2832604

GET https://conductscience.org/api/papers/v1/2832604/cited_by?page=2